Skip to main content
BMC Medicine logoLink to BMC Medicine
. 2016 Dec 20;14:214. doi: 10.1186/s12916-016-0757-5

Erratum to: Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data

WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group1,2
PMCID: PMC5170904  PMID: 27993147

Erratum

After publication of the original article [1], it came to the authors’ attention that there is an error in the originally-published version of Fig. 2. The labelling of the x-axis for Fig. 2 is not correct. The last two values of the x-axis should read: “5-11” instead of “5”, and “12+” instead of “6”.

Fig. 2.

Fig. 2

Measured day 7 lumefantrine concentrations in patients given supervised treatment with the recommended six-dose artemether-lumefantrine regimen, by age and nutrition status. Concentrations are dose-adjusted and scaled for a total dose of 72 mg/kg (after excluding patients with quantifiable lumefantrine concentrations pre-treatment). Outside values are not shown

The correct version of Fig. 2 is published in this erratum.

Footnotes

The online version of the original article can be found under doi:10.1186/s12916-015-0456-7.

Reference

  • 1.WWARN Lumefantrine PK/PD Study Group Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data. BMC Med. 2015;13:227. doi: 10.1186/s12916-015-0456-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Medicine are provided here courtesy of BMC

RESOURCES